Two Sigma Advisers
EOLS icon

Two Sigma Advisers’s Evolus EOLS Stock Holding History

Two Sigma Advisers’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,400
Closed -$129K – 684
2025
Q4 		$129K Sell
19,400
-7,100
-27% -$48.1K ﹤0.01% 2186
2025
Q3 		$163K Sell
26,500
-49,700
-65% -$388K ﹤0.01% 2172
2025
Q2 		$702K Buy
76,200
+500
+0.7% +$5.12K ﹤0.01% 1604
2025
Q1 		$911K Buy
+75,700
New +$990K ﹤0.01% 1513
2022
Q2 		– Sell
-37,900
Closed -$425K – 2712
2022
Q1 		$425K Sell
37,900
-10,500
-22% -$89.5K ﹤0.01% 2065
2021
Q4 		$315K Sell
48,400
-33,200
-41% -$228K ﹤0.01% 2127
2021
Q3 		$622K Buy
81,600
+55,500
+213% +$574K ﹤0.01% 1833
2021
Q2 		$330K Buy
+26,100
New +$287K ﹤0.01% 2108
2019
Q2 		– Sell
-12,900
Closed -$291K – 2355
2019
Q1 		$291K Buy
+12,900
New +$279K ﹤0.01% 1995

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's EOLS Position: Q1 2026 in Review

Two Sigma Advisers sold out of Evolus (EOLS) in Q1 2026, closing a stake of 19,400 shares — an estimated $129K sold.

Two Sigma Advisers first reported a position in EOLS in Q1 2019 and held it in 9 quarters. The position peaked at $911K in Q1 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Two Sigma Advisers reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 19,400 Evolus shares in Q1 2026, an estimated $129K.
  • Two Sigma Advisers first reported a position in Evolus in Q1 2019 and held it in 9 quarters.
  • Two Sigma Advisers's Evolus position peaked at $911K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.